Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study-Reference-Cited by-同舟云学术

Signs and symptoms in relation to progression, experiences of an uncertain illness situation in men with metastatic castration‐resistant prostate cancer—A qualitative study

Published:2022-04-12 Issue:4 Volume:31 Page:
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:European J Cancer Care

Author:

Rönningås Ulrika¹²³^ORCID,Holm Maja³⁴^ORCID,Doveson Sandra¹³^ORCID,Fransson Per⁵⁶^ORCID,Beckman Lars²^ORCID,Wennman‐Larsen Agneta¹³^ORCID

Affiliation:

1. Division of Insurance Medicine, Department of Clinical Neuroscience Karolinska Institutet Stockholm Sweden

2. Department of Oncology Sundsvall County Hospital Sundsvall Sweden

3. Department of Nursing Sciences Sophiahemmet University Stockholm Sweden

4. Department of Health Care Sciences, Palliative Research Centre Marie Cederschiöld University College Stockholm Sweden

5. Department of Nursing Umeå University Umeå Sweden

6. Cancercentrum Norrlands University Hospital Umeå Sweden

Funder

Sjöbergstiftelsen

Publisher

Hindawi Limited

Subject

Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ecc.13592

Reference36 articles.

1. Enzalutamide in Metastatic Prostate Cancer before Chemotherapy

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Understanding symptomatic experience, impact, and emotional response in recently diagnosed metastatic castration-resistant prostate cancer: a qualitative study

4. Living and dying with metastatic bowel cancer: Serial in-depth interviews with patients

5. Patients’ and partners’ views of care and treatment provided for metastatic castrate‐resistant prostate cancer in the UK

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apalutamide for non-metastatic castration-resistant prostate cancer (nmCRPC): real world data of a multicenter study;Journal of Cancer Research and Clinical Oncology;2024-09-09

2. Men's symptom experience throughout androgen deprivation therapy for prostate cancer: A systematic review and meta-aggregation;International Journal of Nursing Studies;2024-09

3. Symptom burden among men treated for castration-resistant prostate cancer: a longitudinal study;BMJ Supportive & Palliative Care;2024-08-08

4. Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study;BMC Palliative Care;2024-03-27